Responses
Clinical/translational cancer immunotherapy
Original research
Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma
Compose a Response to This Article
Other responses
No responses have been published for this article.